Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Reversibility of left ventricular hypertrophy.

Cruickshank JM.

Blood Press Suppl. 1992;1:32-3; discussion 33-4.

PMID:
1343270
2.

Treatment of left ventricular hypertrophy in hypertensive patients.

Tamargo J, Delpón E, Valenzuela C.

Eur Heart J. 1993 Nov;14 Suppl J:102-6. Review.

PMID:
8281952
3.
4.
5.
7.

Left ventricular hypertrophy: how to influence an important risk factor in hypertension.

Agabiti-Rosei E, Muiesan ML.

J Hypertens Suppl. 1998 Jan;16(1):S53-8. Review.

PMID:
9534098
8.

Effects of angiotensin converting enzyme inhibitors on left ventricular hypertrophy.

Morisco C, Argenziano L, Tozzi N, Mele AF, Ricciardelli B, Condorelli G, Trimarco B.

Drugs. 1993;46 Suppl 2:88-94. Review.

PMID:
7512489
9.

Selection of antihypertensive therapy: cardiac and extracardiac considerations.

Messerli FH, Soria F.

Cardiology. 1992;81(4-5):316-24. Review.

PMID:
1301259
10.

Effects of antihypertensive agents on the left ventricle: clinical implications.

Díez J, González A, López B, Ravassa S, Fortuño MA.

Am J Cardiovasc Drugs. 2001;1(4):263-79. Review.

PMID:
14728026
11.
12.

Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy.

Cruickshank JM, Lewis J, Moore V, Dodd C.

J Hum Hypertens. 1992 Apr;6(2):85-90. Review.

PMID:
1534582
13.

Further evidence for low-dose combinations in patients with left ventricular hypertrophy.

Dahlöf B.

J Hum Hypertens. 2005 Jun;19 Suppl 1:S9-14. Review.

PMID:
16075032
15.

Reversibility of left ventricular hypertrophy by antihypertensive drugs.

Fagard RH.

Neth J Med. 1995 Oct;47(4):173-9. Review.

PMID:
8538821
16.

Regression of left ventricular hypertrophy: are there preferred drugs?

Diamond JA, Phillips RA.

Curr Hypertens Rep. 2003 Oct;5(5):368-71. Review.

PMID:
12948428
17.

Regression of left ventricular hypertrophy: do antihypertensive classes differ?

Sheridan DJ.

J Hypertens Suppl. 2000 Jul;18(3):S21-7. Review.

PMID:
10952084
18.

Hypertrophy to failure.

Tanser PH.

J Hum Hypertens. 1994 Sep;8 Suppl 1:S17-20. Review.

PMID:
7807508
19.

Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.

Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI.

Blood Press Monit. 2007 Apr;12(2):87-94.

PMID:
17353651
20.

Left ventricular hypertrophy and antihypertensive therapy.

Messerli FH, Oren S, Grossman E.

Drugs. 1988;35 Suppl 5:27-33. Review.

PMID:
2975215

Supplemental Content

Support Center